The growing interest in oral weight loss medication may make treatment more convenient for patients who do not want weekly injections
Additionally, several key clinical trial readouts delivered compelling data across multiple indications, for example (see Figure 1): Semaglutide : STEP-HFpEF (functional benefits in HFpEF), STEP-9 (pain reduction in knee osteoarthritis), STEP-10 (reversion to normoglycaemia in pre-diabetic, obese patients), ESSENCE (resolution of MASH, improvement in fibrosis) Tirzepatide : SUMMIT (risk reduction in HFpEF outcomes
Changing patterns in BTMs and BMD are similar to those found in calorie restriction interventions: CTX levels increased to a greater extent compared to those of PINP, and total hip BMD decreased to a greater extent compared to lumbar spine BMD [35, 36]
(557) indicated that the group administered 1 g of quercetin daily for two weeks exhibited reduced plasma markers of eccentric muscle injury relative to the placebo group
& Bergheim, I
This work shows their separate and matching roles in repair
